| Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium M Goggins, KA Overbeek, R Brand, S Syngal, M Del Chiaro, DK Bartsch, ... Gut 69 (1), 7-17, 2020 | 531 | 2020 |
| Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection AE Becker, YG Hernandez, H Frucht, AL Lucas World journal of gastroenterology: WJG 20 (32), 11182, 2014 | 460 | 2014 |
| Gut microbiota density influences host physiology and is shaped by host and microbial factors EJ Contijoch, GJ Britton, C Yang, I Mogno, Z Li, R Ng, SR Llewellyn, ... Elife 8, e40553, 2019 | 179 | 2019 |
| Global trends in pancreatic cancer mortality from 1980 through 2013 and predictions for 2017 AL Lucas, M Malvezzi, G Carioli, E Negri, C La Vecchia, P Boffetta, ... Clinical Gastroenterology and Hepatology 14 (10), 1452-1462. e4, 2016 | 112 | 2016 |
| MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions YG Hernandez, AL Lucas World journal of gastrointestinal oncology 8 (1), 18, 2016 | 98 | 2016 |
| High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic … AL Lucas, R Shakya, MD Lipsyc, EB Mitchel, S Kumar, C Hwang, L Deng, ... Clinical Cancer Research 19 (13), 3396-3403, 2013 | 97 | 2013 |
| Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals KA Overbeek, MG Goggins, M Dbouk, IJM Levink, BDM Koopmann, ... Gastroenterology 162 (3), 772-785. e4, 2022 | 92 | 2022 |
| Metformin improves survival in patients with pancreatic ductal adenocarcinoma and pre-existing diabetes: a propensity score analysis S Amin, G Mhango, J Lin, A Aronson, J Wisnivesky, P Boffetta, AL Lucas Official journal of the American College of Gastroenterology| ACG 111 (9 …, 2016 | 81 | 2016 |
| BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts AL Lucas, LE Frado, C Hwang, S Kumar, LG Khanna, EJ Levinson, ... Cancer 120 (13), 1960-1967, 2014 | 80 | 2014 |
| Lynch syndrome and MSI-H cancers: from mechanisms to “off-the-shelf” cancer vaccines V Roudko, C Cimen Bozkus, B Greenbaum, A Lucas, R Samstein, ... Frontiers in immunology 12, 757804, 2021 | 70 | 2021 |
| Screening for pancreatic cancer AL Lucas, F Kastrinos Jama 322 (5), 407-408, 2019 | 54 | 2019 |
| Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis S Amin, AL Lucas, H Frucht Pancreas 42 (2), 249-253, 2013 | 47 | 2013 |
| Early removal of biflanged metal stents in the management of pancreatic walled-off necrosis: a prospective study V Dhir, DG Adler, A Dalal, N Aherrao, R Shah, A Maydeo Endoscopy 50 (06), 597-605, 2018 | 44 | 2018 |
| There is no advantage to transpapillary pancreatic duct stenting for the transmural endoscopic drainage of pancreatic fluid collections: a meta-analysis S Amin, DJ Yang, AL Lucas, S Gonzalez, CJ DiMaio Clinical endoscopy 50 (4), 388-394, 2017 | 44 | 2017 |
| Familial pancreatic cancer and the future of directed screening S Welinsky, AL Lucas Gut and Liver 11 (6), 761, 2017 | 40 | 2017 |
| Dietary total antioxidant capacity and pancreatic cancer risk: an Italian case–control study AL Lucas, C Bosetti, P Boffetta, E Negri, A Tavani, M Serafini, J Polesel, ... British Journal of Cancer 115 (1), 102-107, 2016 | 34 | 2016 |
| The case for early chemotherapy for the treatment of metastatic disease A Lucas, DP Petrylak The Journal of urology 176 (6), S72-S75, 2006 | 34 | 2006 |
| Surveillance for pancreatic cancer in high-risk individuals I Konings, MI Canto, JA Almario, F Harinck, P Saxena, AL Lucas, ... BJS open 3 (5), 656-665, 2019 | 30 | 2019 |
| Molecular tumor testing for Lynch syndrome in patients with colorectal cancer J Matloff, A Lucas, AD Polydorides, SH Itzkowitz Journal of the National Comprehensive Cancer Network 11 (11), 1380-1385, 2013 | 30 | 2013 |
| The role of common pharmaceutical agents on the prevention and treatment of pancreatic cancer S Amin, P Boffetta, AL Lucas Gut and Liver 10 (5), 665, 2016 | 29 | 2016 |
Alexandros D PolydoridesProfessor of Pathology, Icahn School of Medicine at Mount SinaiEmail verificata su mountsinai.org